We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Portable MR Made Possible

By Biotechdaily staff writers
Posted on 05 Aug 2008
Magnetic resonance imaging (MRI) provides enormous insights into the atomic structure of a biomolecule, for instance, or into the tissues of a patient's body. More...
MRI is one of the most important imaging methods used in medicine. However, the modality has one major disadvantage: the machines are huge and extremely expensive, and almost impossible to transport.

Scientists from the Magnetic Resonance working group at the Fraunhofer Institute for Biomedical Technology Engineering IBMT (Sankt Ingbert; Germany) have made MRI mobile. They collaborated with Magritek, (Wellington, New Zealand), a technology spin-off, to develop small portable devices.

Dr. Frank Volke, head of the Magnetic Resonance working group, explained the core technology, "Instead of the large superconducting magnets that have to be cooled with liquid helium and nitrogen, extra-strong permanent magnets are installed in our devices. There is no need for cooling anymore.” To make this possible, several permanent magnets are so arranged that the magnetic field lines overlap to form a homogeneous field. In this way, the developers have succeeded in developing small, less expensive, and above all portable magnetic resonance spectrometers that can even be powered by batteries.

Physicians and researchers all can benefit from the mobile pocket-sized nuclear magnetic resonance (NMR) devices: The first Kea NMR moles are already in use in the Antarctic, helping researchers to study the effects of environmental change by analyzing the structure of ice masses or drilled ice cores. Nevertheless, they cannot replace clinical MRI scanners for whole human body studies. There are many more potential applications for such devices, including delivering important data--directly and online--during production processes. Industrial manufacturers of sausages, cheese, or candies, for instance, can use them to analyze the fat or water content of their food products. The spectrometers can also be employed to measure the humidity of materials, characterize the molecular structure of polymers, or determine the quality of trees for wood production.

Together with Magritek, the Fraunhofer researchers provide technical instruction for users in Germany and Europe and support them with device maintenance.


Related Links:
Fraunhofer Institute for Biomedical Technology Engineering IBMT
Magritek

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.